← Leaderboards
Lexie Shannon Holliday
University Of Florida
$2,010,472
Attributed
$2,010,472
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $240.2K · FY2005–15$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,010,472 · 3
By mechanism
R01$1,196,928 · 1
R21$813,544 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Calogero Dolce$72,500
- Timothy T Wheeler$1,885,991
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Steven L Teitelbaum · Washington University$16,498,459
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yi-Ping Li · Tulane University Of Louisiana$14,733,549
- Yongwon Choi · University Of Pennsylvania$14,421,139
Research focus
OsteoclastsActinsMicrofilamentsLaboratory MouseTissue /Cell CultureSite Directed MutagenesisMediatingMarrowOrthodonticHydrogen TransportIn VitroFunctional DisorderInnovationBaseCalcitriolEndocytosisBinding (Molecular Function)CellsEnzyme MechanismBoneBone MetabolismFutureAdenosinetriphosphataseBone Resorption
Grant awards (9)
Exosomes in Alveolor Bone Remodeling and Root Resorption$187,500
R21 · FY2015 · DE · contact PI
Exosomes in Alveolor Bone Remodeling and Root Resorption$225,000
R21 · FY2014 · DE · contact PI
Dental applications for a novel osteoclast inhibitor$181,294
R21 · FY2011 · DE · contact PI
Dental applications for a novel osteoclast inhibitor$219,750
R21 · FY2010 · DE · contact PI
Osteoclast activation in uremic bone disease$240,231
R01 · FY2005 · AR
Osteoclast activation in uremic bone disease$240,231
R01 · FY2004 · AR
Osteoclast activation in uremic bone disease$240,231
R01 · FY2003 · AR
Osteoclast activation in uremic bone disease$240,231
R01 · FY2002 · AR
Osteoclast activation in uremic bone disease$236,004
R01 · FY2001 · AR